In this study, we recruited 1342 participants, including 741 patients with oral cancer and 601 healthy controls, to determine whether genetic variations in these regions of SERPINB5 and their interactions with oral cancer-related risk factors are associated with susceptibility to and clinicopathological development of oral cancer. Here, SERPINB5 is linked to lip and oral cavity carcinoma.